Exploring the Pharmacological and Clinical Features of Lumateperone: A Promising Novel Antipsychotic
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Rafał R. Jaeschke · 2024
Read Exploring the Pharmacological and Clinical Features of Lumateperone: A Promising Novel Antipsychotic by Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Rafał R. Jaeschke (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678021.txt.
Description
Magdalena Sowa-Kucma and co-authors review lumateperone, a newer drug for schizophrenia, in a 2024 paper. They set out how the drug acts on brain signals and what trials show so far. The drug touches serotonin, dopamine, and glutamate systems at once, which sets it apart from older drugs of its class.
The review notes strong binding at one serotonin site, mid level binding at a dopamine site, and low binding at sites linked to weight gain. Trials cited here found gains for both the active and the flat signs of the illness, with few movement or heart effects. Work on its use for low mood is also covered.
Catalog record
| CREATOR | Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Rafał R. Jaeschke |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |